Ariane König

Prof. Dr. Ariane König

orcid

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 August 1995 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
TST Schwecke
T Schwecke
Jesús F. AparicioJesús F. Aparicio
Jesús F. Aparicio
IMIstvan Molnar
Istvan Molnar
AKAriane König
Ariane König
LKL E Khaw
L E Khaw
JLJ B Lester
J B Lester
The macrocyclic polyketides rapamycin and FK506 are potent immunosuppressants that prevent T-cell proliferation through specific binding to intracellular protein receptors (immunophilins). The cloning and specific alteration of the biosynthetic genes for these polyketides might allow the biosynthesis of clinically valuable analogues. We report here that three clustered polyketide synthase genes responsible for rapamycin biosynthesis in Streptomyces hygroscopicus together encode 14 homologous sets of enzyme activities (modules), each catalyzing a specific round of chain elongation. An adjacent gene encodes a pipecolate-incorporating enzyme, which completes the macrocycle. The total of 70 constituent active sites makes this the most complex multienzyme system identified so far. The DNA region sequenced (107.3 kbp) contains 24 additional open reading frames, some of which code for proteins governing other key steps in rapamycin biosynthesis.

1 December 2017 in Journal of Cleaner Production
Verified
Journal Article
Closed access
CLChristopher Luederitz
Christopher Luederitz
NSNiko Schäpke
Niko Schäpke
AWArnim Wiek
Arnim Wiek
DLDaniel J. Lang
Daniel J. Lang
MBMatthias Bergmann
Matthias Bergmann
FWFrances R. Westley
Frances R. Westley

1 July 2004 in Food and Chemical Toxicology
Verified
Journal Article
Closed access
AKAriane König
Ariane König
ACA. Cockburn
A. Cockburn
RCR.W.R. Crevel
R.W.R. Crevel
EDE. Debruyne
E. Debruyne
RGR. Grafstroem
R. Grafstroem
JWJ.M. Wal
J.M. Wal

30 October 1995 in FEBS Letters
Verified
Journal Article
Closed access
SHStephen F. Haydock
Stephen F. Haydock
Jesús F. AparicioJesús F. Aparicio
Jesús F. Aparicio
IMIstván Molnár
István Molnár
TSTorsten Schwecke
Torsten Schwecke
LKLake Ee Khaw
Lake Ee Khaw
PLPeter F. Leadlay
Peter F. Leadlay

1 February 1996 in Gene
Verified
Journal Article
Closed access
Jesús F. AparicioJesús F. Aparicio
Jesús F. Aparicio
IMIstvan Molnar
Istvan Molnar
TSTorsten Schwecke
Torsten Schwecke
AKAriane König
Ariane König
SHStephen F. Haydock
Stephen F. Haydock
PLPeter F. Leadlay
Peter F. Leadlay

1 December 2001 in Annals of Nutrition and Metabolism
Verified
Journal Article
Open access
PDF file
DJD.A. Jonas
D.A. Jonas
IEI. Elmadfa
I. Elmadfa
KEK.-H. Engel
K.-H. Engel
KHK.J. Heller
K.J. Heller
GKG. Kozianowski
G. Kozianowski
JKJ. Kleiner
J. Kleiner
Recombinant DNA techniques are capable of introducing genetic changes into food organisms that are more predictable than those introduced through conventional breeding techniques. This review discusses whether the consumption of DNA in approved novel foods and novel food ingredients derived from genetically modified organisms (GMOs) can be regarded as being as safe as the consumption of DNA in existing foods. It concludes that DNA from GMOs is equivalent to DNA from existing food organisms that has always been consumed with human diets. Any risks associated with the consumption of DNA will remain, irrespective of its origin, because the body handles all DNA in the same way. The breakdown of DNA during food processing and passage through the gastrointestinal tract reduces the likelihood that intact genes capable of encoding foreign proteins will be transferred to gut microflora. The review does not specifically address food safety issues arising from the consumption of viable genetically modified microorganisms but it shows that the likelihood of transfer and functional integration of DNA from ingested food by gut microflora and/or human cells is minimal. Information reviewed does not indicate any safety concerns associated with the ingestion of DNA per se from GMOs resulting from the use of currently available recombinant DNA techniques in the food chain.